229 related articles for article (PubMed ID: 11708910)
1. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
Zhan ZJ; Bian HL; Wang JW; Shan WG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
[TBL] [Abstract][Full Text] [Related]
5. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
Yu Q; Greig NH; Holloway HW; Brossi A
J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
[TBL] [Abstract][Full Text] [Related]
13. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
[TBL] [Abstract][Full Text] [Related]
14. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
15. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
[TBL] [Abstract][Full Text] [Related]
16. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity.
Siwicka A; Moleda Z; Wojtasiewicz K; Zawadzka A; Maurin JK; Panasiewicz M; Pacuszka T; Czarnocki Z
J Pineal Res; 2008 Aug; 45(1):40-9. PubMed ID: 18284552
[TBL] [Abstract][Full Text] [Related]
17. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase inhibitors: SAR and kinetic studies on omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives.
Rampa A; Piazzi L; Belluti F; Gobbi S; Bisi A; Bartolini M; Andrisano V; Cavrini V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2001 Nov; 44(23):3810-20. PubMed ID: 11689067
[TBL] [Abstract][Full Text] [Related]
19. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
Więckowska A; Bajda M; Guzior N; Malawska B
Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]